ProfileGDS4718 / 202704_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 97% 98% 97% 98% 97% 98% 98% 98% 98% 98% 98% 98% 97% 97% 99% 98% 96% 96% 96% 97% 97% 98% 98% 97% 97% 97% 97% 98% 98% 96% 91% 98% 98% 98% 98% 97% 97% 98% 97% 99% 98% 96% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.997797
GSM549102patient 115, normal, homogenized [OPG study]11.145897
GSM549104patient 119, normal, homogenized [OPG study]11.211598
GSM549108patient 138, normal, homogenized [OPG study]11.159697
GSM549119patient 077, normal, homogenized [OPG study]11.500798
GSM549133patient 032, cancer, homogenized [OPG study]11.024797
GSM549139patient 042, cancer, homogenized [OPG study]11.154598
GSM549099patient 107, normal, homogenized [OPG study]11.23698
GSM549109patient 139, normal, homogenized [OPG study]11.662998
GSM549110patient 046, normal, homogenized [OPG study]11.428898
GSM549114patient 063, normal, homogenized [OPG study]11.674198
GSM549122patient 082, normal, homogenized [OPG study]11.384598
GSM549134patient 033, cancer, homogenized [OPG study]11.190398
GSM549136patient 036, cancer, homogenized [OPG study]10.965497
GSM549140patient 044, cancer, homogenized [OPG study]10.913197
GSM549111patient 047, normal, homogenized [OPG study]12.106999
GSM549113patient 057, normal, homogenized [OPG study]11.789998
GSM549132patient 031, cancer, homogenized [OPG study]10.492996
GSM549137patient 038, cancer, homogenized [OPG study]10.489596
GSM549142patient 047, cancer, homogenized [OPG study]10.146496
GSM549100patient 110, normal, homogenized [OPG study]11.205697
GSM549107patient 135, normal, homogenized [OPG study]11.251297
GSM549115patient 068, normal, homogenized [OPG study]11.56698
GSM549116patient 072, normal, homogenized [OPG study]11.488998
GSM549120patient 078, normal, homogenized [OPG study]11.262497
GSM549131patient 030, cancer, homogenized [OPG study]10.982497
GSM549118patient 074, normal, homogenized [OPG study]11.127697
GSM549129patient 027, cancer, homogenized [OPG study]10.599497
GSM549123patient 088, normal, homogenized [OPG study]11.403298
GSM549124patient 006, cancer, homogenized [OPG study]11.38898
GSM549126patient 015, cancer, homogenized [OPG study]10.335196
GSM549128patient 025, cancer, homogenized [OPG study]9.4367191
GSM549103patient 117, normal, homogenized [OPG study]11.416698
GSM549117patient 073, normal, homogenized [OPG study]11.490598
GSM549138patient 041, cancer, homogenized [OPG study]11.610498
GSM549141patient 045, cancer, homogenized [OPG study]11.71998
GSM549130patient 028, cancer, homogenized [OPG study]10.882697
GSM549101patient 111, normal, homogenized [OPG study]10.668197
GSM549105patient 128, normal, homogenized [OPG study]11.638998
GSM549106patient 134, normal, homogenized [OPG study]11.244697
GSM549112patient 048, normal, homogenized [OPG study]12.055399
GSM549125patient 011, cancer, homogenized [OPG study]11.613398
GSM549127patient 024, cancer, homogenized [OPG study]10.509496
GSM549135patient 035, cancer, homogenized [OPG study]11.287898